GOLDMAN SACHS GROUP INC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 175 filers reported holding CLOVIS ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$166,000
-61.8%
139,904
-42.1%
0.00%
Q2 2022$435,000
-27.5%
241,621
-18.7%
0.00%
Q1 2022$600,000
-55.2%
297,021
-39.9%
0.00%
Q4 2021$1,340,000
-40.4%
494,457
-1.8%
0.00%
Q3 2021$2,247,000
+7.3%
503,752
+39.5%
0.00%
Q2 2021$2,094,000
-61.9%
361,026
-53.9%
0.00%
-100.0%
Q1 2021$5,498,000
+67.4%
783,149
+14.5%
0.00%0.0%
Q4 2020$3,284,000
+87.2%
684,199
+127.4%
0.00%
Q3 2020$1,754,000
+53.7%
300,872
+78.0%
0.00%
Q2 2020$1,141,000
-90.4%
168,984
-91.0%
0.00%
-100.0%
Q1 2020$11,917,000
+45.8%
1,873,793
+139.1%
0.00%
+100.0%
Q4 2019$8,171,000
+218.9%
783,702
+20.2%
0.00%
+100.0%
Q3 2019$2,562,000
-68.9%
651,778
+17.7%
0.00%
-50.0%
Q2 2019$8,234,000
-53.2%
553,740
-21.9%
0.00%
-60.0%
Q1 2019$17,597,000
+189.9%
708,970
+109.8%
0.01%
+400.0%
Q4 2018$6,069,000
-41.7%
337,937
-4.6%
0.00%
-66.7%
Q3 2018$10,404,000
-43.8%
354,234
-13.0%
0.00%
-40.0%
Q2 2018$18,523,000
-13.4%
407,364
+0.5%
0.01%0.0%
Q1 2018$21,397,000
-15.8%
405,241
+8.4%
0.01%
-16.7%
Q4 2017$25,421,000
-21.8%
373,838
-5.2%
0.01%
-25.0%
Q3 2017$32,505,000
-27.2%
394,486
-17.3%
0.01%
-27.3%
Q2 2017$44,678,000
+13.0%
477,164
-23.1%
0.01%0.0%
Q1 2017$39,527,000
+9.6%
620,815
-23.5%
0.01%0.0%
Q4 2016$36,059,000
-5.0%
811,767
-22.9%
0.01%
-8.3%
Q3 2016$37,940,000
+45.9%
1,052,420
-44.5%
0.01%
+33.3%
Q2 2016$26,013,000
+16.1%
1,896,027
+62.5%
0.01%
+28.6%
Q1 2016$22,401,000
-69.2%
1,166,729
-43.8%
0.01%
-69.6%
Q4 2015$72,679,000
+826.2%
2,076,532
+2333.5%
0.02%
+666.7%
Q3 2015$7,847,000
-27.4%
85,330
-30.6%
0.00%0.0%
Q2 2015$10,810,000
+12.5%
123,009
-5.0%
0.00%0.0%
Q1 2015$9,609,000
-50.1%
129,447
-62.3%
0.00%
-50.0%
Q4 2014$19,249,000
+12.0%
343,740
-9.3%
0.01%0.0%
Q3 2014$17,184,000
+3.9%
378,836
-5.2%
0.01%
+20.0%
Q2 2014$16,543,000
-1.5%
399,500
+64.7%
0.01%0.0%
Q1 2014$16,799,000
+72.3%
242,518
+49.9%
0.01%
+66.7%
Q4 2013$9,752,000
-7.3%
161,798
-6.5%
0.00%
-25.0%
Q3 2013$10,516,000
+285.6%
172,961
+324.8%
0.00%
+300.0%
Q2 2013$2,727,00040,7160.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders